Real-world treatment patterns and outcomes of patients treated with commercial chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma

Publication Date

2026

Content Type

article

PubMed ID:

42642985

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS